212 related articles for article (PubMed ID: 26463658)
1. Natural and Synthetic Flavonoids: Structure-Activity Relationship and Chemotherapeutic Potential for the Treatment of Leukemia.
Menezes JC; Orlikova B; Morceau F; Diederich M
Crit Rev Food Sci Nutr; 2016 Jul; 56 Suppl 1():S4-S28. PubMed ID: 26463658
[TBL] [Abstract][Full Text] [Related]
2. Relationship between structure and antiproliferative, proapoptotic, and differentiation effects of flavonoids on chronic myeloid leukemia cells.
Ramanouskaya TV; Smolnykova VV; Grinev VV
Anticancer Drugs; 2009 Aug; 20(7):573-83. PubMed ID: 19491655
[TBL] [Abstract][Full Text] [Related]
3. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids as P-gp Inhibitors: A Systematic Review of SARs.
Cui J; Liu X; Chow LMC
Curr Med Chem; 2019; 26(25):4799-4831. PubMed ID: 30277144
[TBL] [Abstract][Full Text] [Related]
5. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1997; 17():390-407. PubMed ID: 9551222
[No Abstract] [Full Text] [Related]
6. ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model.
Nasr RR; Hmadi RA; El-Eit RM; Iskandarani AN; Jabbour MN; Zaatari GS; Mahon FX; Pisano CC; Darwiche ND
Int J Cancer; 2015 Aug; 137(3):698-709. PubMed ID: 25557649
[TBL] [Abstract][Full Text] [Related]
7. Chemomodulating Effects of Flavonoids in Human Leukemia Cells.
Sak K; Everaus H
Anticancer Agents Med Chem; 2015; 15(9):1112-26. PubMed ID: 25986578
[TBL] [Abstract][Full Text] [Related]
8. Flavokawain B inhibits the growth of acute lymphoblastic leukemia cells via p53 and caspase-dependent mechanisms.
Tang YL; Huang LB; Tian Y; Wang LN; Zhang XL; Ke ZY; Deng WG; Luo XQ
Leuk Lymphoma; 2015; 56(8):2398-407. PubMed ID: 25641429
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids: promising anticancer agents.
Ren W; Qiao Z; Wang H; Zhu L; Zhang L
Med Res Rev; 2003 Jul; 23(4):519-34. PubMed ID: 12710022
[TBL] [Abstract][Full Text] [Related]
10. [Advances in the structure-activity relationship study of natural flavonoids and its derivatives].
Zhong JQ; Li B; Jia Q; Li YM; Zhu WL; Chen KX
Yao Xue Xue Bao; 2011 Jun; 46(6):622-30. PubMed ID: 21882520
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells.
Landis-Piwowar KR; Milacic V; Dou QP
J Cell Biochem; 2008 Oct; 105(2):514-23. PubMed ID: 18636546
[TBL] [Abstract][Full Text] [Related]
12. Methylenedioxy flavonoids: assessment of cytotoxic and anti-cancer potential in human leukemia cells.
Orlikova B; Menezes JC; Ji S; Kamat SP; Cavaleiro JA; Diederich M
Eur J Med Chem; 2014 Sep; 84():173-80. PubMed ID: 25016375
[TBL] [Abstract][Full Text] [Related]
13. Cycloartobiloxanthone Induces Human Lung Cancer Cell Apoptosis
Losuwannarak N; Sritularak B; Chanvorachote P
In Vivo; 2018; 32(1):71-78. PubMed ID: 29275301
[TBL] [Abstract][Full Text] [Related]
14. The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities.
Zhu JY; Lavrik IN; Mahlknecht U; Giaisi M; Proksch P; Krammer PH; Li-Weber M
Int J Cancer; 2007 Oct; 121(8):1839-46. PubMed ID: 17565740
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells.
Plochmann K; Korte G; Koutsilieri E; Richling E; Riederer P; Rethwilm A; Schreier P; Scheller C
Arch Biochem Biophys; 2007 Apr; 460(1):1-9. PubMed ID: 17353006
[TBL] [Abstract][Full Text] [Related]
16. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic and apoptotic effects of prenylflavonoid artonin B in human acute lymphoblastic leukemia cells.
Lee CC; Lin CN; Jow GM
Acta Pharmacol Sin; 2006 Sep; 27(9):1165-74. PubMed ID: 16923337
[TBL] [Abstract][Full Text] [Related]
18. The antitumor activities of flavonoids.
Kandaswami C; Lee LT; Lee PP; Hwang JJ; Ke FC; Huang YT; Lee MT
In Vivo; 2005; 19(5):895-909. PubMed ID: 16097445
[TBL] [Abstract][Full Text] [Related]
19. Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
van Besien H; Sassano A; Altman JK; Platanias LC
Leuk Lymphoma; 2013 Dec; 54(12):2601-5. PubMed ID: 23540342
[TBL] [Abstract][Full Text] [Related]
20. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
